Zdrowie i gospodarka · 12.07.1996
Abbott Laboratories; Premarket Approval of Abbott PGR-ICA Monoclonal
The Food and Drug Administration (FDA) is announcing its approval of the application submitted by Abbott Laboratories, Abbott Park, IL, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of Abbott PGR-ICA Monoclonal. FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of September 26, 1995, of the approval of the application.